姓名：党永军
职称：研究员
E-MAIL: yongjundang@fudan.edu.cn
?
?
?
?
研究方向
1. 分子药理
2. 活性小分子发现和作用机理研究
重要学术贡献
实验室针对当前药物新靶标匮乏和发现困难的现状，建立基于模式动物、细胞和靶标的多维药物筛选、疾病相关靶标和活性小分子靶标鉴定和确证技术体系，紧密与临床相结合，取得了一系列成果。申请人的研究领域是化学生物学和分子药理，分别参与了天然产物Pateamine A、Mycalamdie B、Lactimidomycin、Cycloheximide; 和临床药物Triptolide（雷公藤的主要有效成分）、Itraconazole(抗真菌)、Clofazimine（抗麻风病药）和青蒿素类等活性分子作用靶点的鉴定和作用机理的研究。另外发现P4HA2、USP9X等基因与肿瘤发生发展的关系，提供肿瘤治疗的新的作用靶标。共发表 SCI收录的文章50多篇。其中第一作者或者通讯作者发表论文11篇。论文分别发表在Blood, Nucleic Acids Res, Oncogene, Molecular Cell, Journal of Biological Chemistry, RNA, PNAS, Nature Chemical Biology，JACS等知名期刊。目前文章已经被引用超过2200次，H因子21。
荣誉与获奖
上海市人才发展基金
国内外学术团体任职
2007年至今，美国化学学会会员
2015年至今，上海药物学会，海洋药物委员会会员
?? ?
受邀审稿学术刊物
校内学术机构任职
受邀学术报告
2017?? ?Strategies for Target Identification and Validation of Bioactive Marine Natural Compounds，第十三届海洋药物学术年会暨2017国际海洋药物研讨会，青岛

发表论文（以第一或通讯作者发表，通讯作者以*标出，从2018年起倒序排列。选不超过10篇代表性论文用黄色高亮标出。）
1.? Jiang W, Zhou X, Li Z, Liu K, Wang W, Tan R, Cong X, Shan J, Zhan Y, Cui Z, Jiang L, Li Q, Shen S, Bai M, Cheng Y, Li B, Tan M, Ma D, Liu J.O, Dang Y* Prolyl 4-Hydroxylase 2 Promotes B-cell Lymphoma Progression via Hydroxylation of Carabin. Blood. 2018 (published online)
2. Li Z, Cheng Z , Raghothama C, Cui Z, Liu K, Li X, Jiang C, Jiang W, Tan M, Ni X, Pandey A, Liu J.O, Dang Y*. (2018) USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1. Nucleic Acid Research. 46(2) 823–839
3.Yao Y, Sun S, Fei F, Wang J, Wang Y, Zhang R, Wu J, Liu L, Liu X, Cui Z, Li Q, Yu M, Dang Y* , Wang X*. (2017)? Screening in larval zebrafish reveals tissue-specific distribution offifteen fluorescent compounds. Disease Models & Mechanisms 10, 1155-1164
4. Lu P, Zhang F, Qian S, Li X, Cui Z, Dang Y*, Tang QQ*. (2016) Artemisinin derivatives prevent obesity by inducing browning of WAT and enhancing BAT function. Cell Res. 26(10):1169-1172. ?
5.Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, Dang Y, Chu Y, Fan J, He R.(2016)FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling. Cancer Res. 15;76(14):4124-35. doi: 10.1158/0008-5472.CAN-15-2973.
6.Lu J, Jiang C, Li X, Jiang L, Li Z, Schneider-Poetsch T, Liu J, Yu K, Liu J.O, Jiang H, Luo C*, Dang Y*. (2015) A gating mechanism for Pi release governs the mRNA unwinding by eIF4AI during translation initiation. Nucleic Acid Research. 43(21):10157-67.
7.Zhu C, Zhu X, Landry JP, Cui Z, Li Q, Dang Y, Mi L, Zheng F, Fei Y. (2016) Developing an Efficient and General Strategy for Immobilization of Small Molecules onto Microarrays Using Isocyanate Chemistry. Sensors (Basel). 16;16(3)
8.?? ?Liu Y, Ge X, Dou X, Guo L, Liu Y, Zhou SR, Wei XB, Qian SW, Huang HY, Xu CJ, Jia WP, Dang Y, Li X, Tang QQ. (2015)Protein Inhibitor of Activated STAT 1 (PIAS1) Protects Against Obesity-Induced Insulin Resistance by Inhibiting Inflammation Cascade in Adipose Tissue. Diabetes. 64(12):4061-74.
9.?? ?Fu Y, Lv P, Yan G, Fan H, Cheng L, Zhang F, Dang Y, Wu H, Wen B. (2015)MacroH2A1 associates with nuclear lamina and maintains chromatin architecture in mouse liver cells. Sci Rep. 25;5:17186.
10.Jia X, Ma K, Xu T, Gao L, Wu S, Fu C, Zhang W, Wang Z, Liu K, Dong M, Jing C, Ren C, Dong Z, Chen Y, Jin Y, Huang Q, Chang X, Deng M, Li L, Luo L, Zhu J, Dang Y, Chang H, Zon L, Zhou Y, Chen S, Pan W. (2015) Mutation of kri1l causes definitive hematopoiesis failure via PERK-dependent excessive autophagy induction. Cell Res. 25(8):946-62.
11.Huang H, Zhang W, Jiang W, Chen S, Liu Y, Ge X, Li X, Dang Y, Wen B, Liu XH, Lu H, Tang Q. (2015) RhoGDIβ Inhibits Bone Morphogenetic Protein 4 (BMP4)-induced Adipocyte Lineage Commitment and Favors Smooth Muscle-like Cell Differentiation. J Biol Chem. 24;290(17):11119-29.
12.Jiang W, Huang H, Ding L, Zhu P, Saiyin H, Ji G, Zuo J, Han D, Pan Y, Ding D, Ma X, Zhang Y, Wu J, Yi Q, Liu JO, Huang H, Dang Y*, Yu L*. (2014)? Regulation of cell cycle of hepatocellular carcinoma by NF90 through modulation of cyclin E1 mRNA stability. Oncogene. 20;34(34):4460-70.
13.Rao F, Xu J, Khan A, Gadalla M, Cha J, Xu R, Tyagi R, Dang Y, Chakraborty A, Snyder SH.? Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16005-10
14.Liu Z, Wu D, Shia Y, Zeng T, Liu S, Du X, Dang Y*, Xiao W*, Sun H*. (2014)? Three new diterpenoids from Leonurus. Chinese Chemical Letters 25, 677-679.
15.Liu Y, Zhang Y, Guo L, Huang H, Zhu H, Huang J, Liu Y, Zhou S, Dang Y, Li X, and Tang Q.(2013). Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis. Mol Cell Biol 33(22):4606-17.
16.Guo L, Huang J, Liu Y, Li X, Zhou S, Qian S, Liu Y, Zhu H, Huang H, Dang Y, Tang Q. (2013). Transactivation of Atg4b by C/EBPβpromotes autophagy to facilitate adipogenesis. Mol Cell Biol. 33(16):3180-90.
17.Kong X, Peng B, Yang Y, Zhang P, Qin B, Han D, Wang C, Dang Y, Liu JO, Yu L. (2013). p53 Represses transcription of RING finger LIM domain-binding protein RLIM through Sp1. PLoS One. 8(5):e62832.
18.Dang Y, Schneider-Poetsch T, Eyler DE, Jewett JC, Bhat S, Rawal VH, Green R, and Liu JO. (2011) Inhibition of Eukaryotic Translation Elongation by the Antitumor Natural Product Mycalamide B. RNA 17(8), 1578-1588
19.Titov DV, Gilman? B, He QL, Bhat S, Low WK, Dang Y, Smeaton M, Demain AJ, Miller PS, Kugel JF, Goodrich JA & Liu JO, (2011) XPB, a subunit of TFIIH, is a target of the natural product triptolide. Nature Chemical Biology 7(3):182-8.
20.Chamni S, He QL, Dang Y, Bhat S, Liu JO, and Romo D, (2011) Diazo Reagents with Small Steric Footprints for Simultaneous Arming/SAR Studies of Alcohol-Containing Natural Products via O–H Insertion. ACS Chemical Biology (11):1175-81.
21. Liu JO, Titov D, Dang Y, and He QL. (2011) Regulator of Ras Depalmitoylation and Retrograde Trafficking: A New Hat for FKBP. Molecular Cell 21;41(2):131-3.
22.Huang W, Ding L, Huang Q, Hu H, Liu S, Yang X, Hu X, Dang Y, Shen S, Li J, Ji X, Jiang S, Liu JO, Yu L. (2010) Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma.? Hepatology 52(2), 703 – 714.
23.Schneider-Poetsch T, Ju J, Eyler DE, Dang Y, Bhat S, Merrick WC, Green R, Shen B, Liu JO. (2010). Inhibition of Eukaryotic Translation Elongation via the Ribosomal E-site by Cycloheximide and Lactimidomycin. Nature Chemical Biology 6(3):209-217.
24. Li W, Dang Y, Liu JO, Yu B. (2010). Structural and stereochemical requirements of the spiroketal group of hippuristanol for antiproliferative activity. Bioorg Med Chem Lett. 20(10):3112-5.
25.Xu J, Dang Y, Ren YR, Liu JO. (2010). Cholesterol trafficking is required for mTOR activation in endothelial cells. Proc Natl Acad Sci U S A. 107(10):4764-9.
26.Dang Y, Low W.K, Xu J, Gehring N.H, Dietz H.C, Romo D, and Liu J.O. (2009). Inhibition of nonsense-mediated mRNA decay by the natural product pateamine A through eukaryotic initiation factor 4AIII. J Biol Chem 284, 23613-23621.
27.Li W., Dang Y., Liu J.O., and Yu B. (2009). Expeditious Synthesis of Hippuristanol and Congeners with Potent Antiproliferative Activities. Chemistry 15, 10356-10359.
28.?? ?Dang Y, Kedersha N, Low, W.K, Romo D, Gorospe M, Kaufman R, Anderson P, and Liu J.O. (2006). Eukaryotic initiation factor 2alpha-independent pathway of stress granule induction by the natural product pateamine A. J Biol Chem 281, 32870-32878.
29.Ren Y, Pan F, Parvez S, Fleig A, Chong C.R, Xu J, Dang Y, Zhang J, Jiang H, Penner R (2008). Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes. PLoS One 3, e4009.
(Highlighted in Johns Hopkins Gazette on Febrary 16, 2009 “ Old Meds Hold Promise As Therapy for Autoimmune Diseases”)
30.Galban S, Kuwano Y, Pullmann R, Jr, Martindale J.L, Kim H.H. Lal, A. Abdelmohsen K., Yang X., Dang Y, Liu J.O., et al. (2008). RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1alpha. Mol Cell Biol 28, 93-107.
31.Pei Y, Zhu P, Dang Y, Wu J, Yang X, Wan B, Liu J.O, Yi Q, and Yu L. (2008). Nuclear export of NF90 to stabilize IL-2 mRNA is mediated by AKT-dependent phosphorylation at Ser647 in response to CD28 costimulation. J Immunol 180, 222-229.
32.Low W.K, Dang Y, Bhat S, Romo D, and Liu J.O. (2007). Substrate-dependent targeting of eukaryotic translation initiation factor 4A by pateamine A: negation of domain-linker regulation of activity. Chem Biol 14, 715-727.
33.Hu X, Dang Y, Tenney K, Crews P, Tsai C.W, Sixt K.M, Cole P.A, and Liu J.O. (2007). Regulation of c-Src nonreceptor tyrosine kinase activity by bengamide A through inhibition of methionine aminopeptidases. Chem Biol 14, 764-774.
34.Peddibhotla S, Dang Y, Liu J.O, and Romo D. (2007). Simultaneous arming and structure/activity studies of natural products employing O-H insertions: an expedient and versatile strategy for natural products-based chemical genetics. J Am Chem Soc 129, 12222-12231.
(Highlighted in C&EN News “Tagging Natural Products” on Oct. 1, 2007)
35.Wu J, Dang Y, Su W, Liu C, Ma H, Shan Y, Pei Y, Wan B, Guo J, and Yu L. (2006). Molecular cloning and characterization of rat LC3A and LC3B--two novel markers of autophagosome. Biochem Biophys Res Commun 339, 437-442.
36.Low W.K, Dang Y, Schneider-Poetsch T, Shi Z, Choi N.S, Merrick W.C, Romo D, and Liu J.O. (2005). Inhibition of eukaryotic translation initiation by the marine natural product pateamine A. Mol Cell 20, 709-722.
(Featured in the review by Dr. Jon Clardy in ACS Chemical Biology “ Stopping Trouble before It starts” 2005 Vol. 1 No. 1 p17; Highlighted in C & EN News “Protein Synthesis Nipped in the Bud” on December 19, 2005; Commented in “Faculty of 1000”)
37.Liu L, Zhang J, Yuan J, Dang Y, Yang C, Chen X, Xu J, and Yu L. (2005). Characterization of a human regulatory subunit of protein phosphatase 3 gene (PPP3RL) expressed specifically in testis. Mol Biol Rep 32, 41-45.
38. Zhou G.J, Zhang Y, Wang J, Guo J.H, Ni J, Zhong Z.M, Wang L.Q, Dang Y, Dai J.F, and Yu L. (2004). Cloning and characterization of a novel human RNA binding protein gene PNO1. DNA Seq 15, 219-224.
39.He H, Dang Y, Dai F, Guo, Z, Wu J, She X, Pei Y, Chen Y, Ling W, Wu C (2003). Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. J Biol Chem 278, 29278-29287. ?
40.Li D, Yu L, Wu H, Shan Y, Guo J, Dang Y, Wei Y, and Zhao S. (2003). Cloning and identification of the human LPAAT-zeta gene, a novel member of the lysophosphatidic acid acyltransferase family. J Hum Genet 48, 438-442.
41.Shu F, Guo S, Dang Y, Qi M, Zhou G, Guo Z, Zhang Y, Wu C, Zhao S, and Yu L. (2003). Human aurora-B binds to a proteasome alpha-subunit HC8 and undergoes degradation in a proteasome-dependent manner. Mol Cell Biochem 254, 157-162.
学术专著
申请或授权专利
授权专利
1.? “Anticancer agents and use”? United States Patent **
2.? “New Target for inhibition of Angiogenesis” JHU Ref: C11009
申请专利
1.“一种诊断B淋巴瘤和白血病的标记物、试剂盒及其应用”
2.蒿甲醚在制备促进脂肪分解和改善糖代谢制剂中的用途（国内、国际专利）3.5
?
?